<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During the past several decades, the incidence of <z:hpo ids='HP_0001513'>obesity</z:hpo> has significantly increased worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Enormous efforts have been devoted to understanding the molecular mechanisms underlying <z:hpo ids='HP_0001513'>obesity</z:hpo> and its related <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> such as type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>It is now well-established that altered adipocyte metabolism in <z:mp ids='MP_0001261'>obese</z:mp> patients is closely associated with the induction of various metabolic stresses including <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo>, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>However, the cellular factor(s) which sense metabolic changes and/or initiate the pathological progression of <z:hpo ids='HP_0001513'>obesity</z:hpo>-induced <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> remain to be elucidated </plain></SENT>
<SENT sid="4" pm="."><plain>In this review, we will discuss the possible roles of cellular <z:chebi fb="0" ids="18009">NADP(+)</z:chebi>/<z:chebi fb="1" ids="16474">NADPH</z:chebi>, which function as redox potential regulators, in the induction of <z:hpo ids='HP_0001513'>obesity</z:hpo>-associated <z:mp ids='MP_0003674'>oxidative stress</z:mp>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp>, and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and suggest G6PD, a <z:chebi fb="1" ids="16474">NADPH</z:chebi>-generating enzyme, as a novel target for treating <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> </plain></SENT>
</text></document>